Sign in

You're signed outSign in or to get full access.

IC

Ingevity Corp (NGVT)·Q1 2025 Earnings Summary

Executive Summary

  • Q1 2025 net sales were $284.0M, down 17% YoY on deliberate exits in Performance Chemicals; adjusted EBITDA rose 23% to $91.3M with margin expanding to 32.1%, the fourth straight quarter of YoY margin improvement .
  • Results vs consensus: adjusted EPS $0.99 was above $0.74*, revenue $284.0M was roughly in line/slightly below $285.5M*, and adjusted EBITDA $91.3M exceeded $80.3M* .
  • Guidance widened due to auto production/tariff uncertainty: FY25 sales $1.25–$1.40B (from $1.30–$1.40B) and adjusted EBITDA $380–$415M (from $400–$415M); leverage target <2.8x maintained, FCF guide affirmed on the call .
  • Catalysts: continued margin/mix strength in Performance Materials, APT margin improvement ahead of Q2 outage, and tangible PC restructuring benefits; watch tariff-driven auto forecasts and Industrial Specialties strategic review timing .

What Went Well and What Went Wrong

  • What Went Well

    • “Best-in-class profitability” narrative backed by 32.1% adjusted EBITDA margin; fourth consecutive YoY margin expansion .
    • Performance Materials strength: sales +1% to $146.8M, segment EBITDA $79.1M, margin ~53.9%, aided by pricing and favorable mix (hybrids/turbo/stop-start) .
    • APT margins improved to 29.6% with EBITDA +$3M to $12.5M, driven by higher utilization and pre-outage inventory build .

  • What Went Wrong

    • Net sales -17% YoY to $284.0M, primarily from Performance Chemicals repositioning and weaker Industrial Specialties demand .
    • Performance Chemicals sales -35% to $95.0M; segment EBITDA still slightly negative (-$0.3M), though improved by $10.3M YoY .
    • Management widened FY25 ranges due to auto forecast cuts tied to tariffs/trade uncertainty; PM EBITDA could be $15–$20M lower if North America auto production declines ~9–10% .

Financial Results

MetricQ1 2024Q4 2024Q1 2025
Net Sales ($USD Millions)$340.1 $298.8 $284.0
Diluted Adjusted EPS ($USD)$0.47 $0.95 $0.99
Adjusted EBITDA ($USD Millions)$74.4 $80.6 $91.3
Adjusted EBITDA Margin (%)21.9% 27.0% 32.1%
Net Income Margin (%)(16.5%) 5.6% 7.2%

Segment breakdown

MetricQ1 2024Q4 2024Q1 2025
Performance Materials Sales ($M)$145.1 $156.2 $146.8
Performance Materials EBITDA ($M)$78.0 $78.3 $79.1
Performance Chemicals Sales ($M)$147.0 $98.7 $95.0
Road Technologies Sales ($M)$45.7 $48.5 $44.3
Industrial Specialties Sales ($M)$101.3 $50.2 $50.7
Performance Chemicals EBITDA ($M)($10.6) ($3.8) ($0.3)
APT Sales ($M)$48.0 $43.9 $42.2
APT EBITDA ($M)$9.5 $6.1 $12.5

KPIs

KPIQ1 2024Q4 2024Q1 2025
Operating Cash Flow ($M)($12.1) $64.5 $25.4
Free Cash Flow ($M)($28.7) $39.6 $15.4
Net Leverage (x)N/A3.5x 3.3x
Capital Expenditure ($M)$16.6 $24.9 $10.0

Versus consensus (Q1 2025)

MetricConsensus*Actual
Revenue ($USD Millions)$285.47*$284.0
Diluted Adjusted EPS ($USD)$0.7375*$0.99
Adjusted EBITDA ($USD Millions)$80.33*$91.3
Values retrieved from S&P Global.*

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
Sales ($USD Billions)FY 2025$1.30–$1.40B $1.25–$1.40B Lowered low end
Adjusted EBITDA ($USD Millions)FY 2025$400–$415M $380–$415M Lowered low end
Free Cash Flow ($USD Millions)FY 2025$220–$260M Affirmed on call Maintained
Net Leverage (x)FY 2025<2.8x <2.8x (affirmed) Maintained

Earnings Call Themes & Trends

TopicPrevious Mentions (Q3 2024)Previous Mentions (Q4 2024)Current Period (Q1 2025)Trend
Tariffs/macroWeather and industrial softness cited; portfolio review underway Focus on debt reduction, margins in high-20s, macro caution Direct tariff impact expected minimal; widened guidance to reflect ~10% NA auto decline Heightened caution
Auto mix and PMPM margins >50%; operational efficiencies, hybrids/ICE mix favorable Record PM year; expect ~50% margins in 2025 PM margins ~54%; pricing annual increases; sensitivity −$15–$20M EBITDA if NA auto down 9–10% Strong but sensitive
Performance Chemicals (PC)Exit low-margin IS, CTO contract termination; margins improving PC EBITDA $14.7M FY24; remaining high-cost CTO through Q2 2025 PC EBITDA near breakeven; benefits from cost/mix, lower raw material costs Improving
APT pricing/competitionVolumes recovered; pricing/mix headwinds, FX drag 18.7% FY margin; expect ~20% in 2025 Margin 29.6% helped by utilization; increased competition in China Mixed
Free cash flow/leverageFCF constrained by CTO termination; plan to delever FCF $51M; leverage 3.5x; guide FCF $220–$260M FCF $15.4M; leverage 3.3x; leverage target <2.8x affirmed Improving
EVs/NexeonBattery/Si anode opportunity noted; PM content strong in hybrids PM R&D includes EV/battery initiatives EV slowdown acknowledged; Nexeon still strategic; hybrids supportive Steady investment

Management Commentary

  • “The company delivered a strong first quarter… fourth consecutive quarter of year-over-year margin expansion. This quarter was an example of the best-in-class profitability Ingevity is capable of.” — David Li, CEO .
  • “Adjusted EBITDA was up $17 million and margins improved from 21.9% to 32.1%. This is our fourth consecutive quarter of year-over-year gross margin and EBITDA margin improvement.” — Mary Dean Hall, CFO .
  • “We’ve widened our guidance range for sales and EBITDA to reflect the impact of a 10% reduction in North American auto production.” — David Li, CEO .

Q&A Highlights

  • Performance Materials pricing/tariffs: annual price increase executed; local-for-local production and localization mitigate tariff risks; direct tariff impact expected minimal .
  • Industrial Specialties strategic review: process “progressing well” with broad interest; update expected before year-end .
  • Free cash flow resiliency: in lower sales scenarios, working capital release can bolster FCF; CFO “comfortable affirming” FCF guide .
  • EV slowdown vs Nexeon: EV adoption slows but battery tech remains a growth platform; hybrids supportive of PM demand .
  • Filtration pivot: sizable market can absorb capacity if auto weakens, albeit lower margin than auto .
  • Leverage target: long-term goal remains 2.0–2.5x; <2.8x by year-end affirmed .

Estimates Context

  • Q1 2025 comparisons: EPS $0.99 vs $0.7375* (beat); revenue $284.0M vs $285.47M* (inline/slight miss); adjusted EBITDA $91.3M vs $80.33M* (beat) .
  • Implications: PM robustness and PC cost/mix tailwinds support upward margin revisions; widened FY sales/EBITDA ranges and auto sensitivity likely temper top-line expectations near term .
    Values retrieved from S&P Global.*

Key Takeaways for Investors

  • Margin story intact: consolidated adjusted EBITDA margin reached 32.1% with PM at ~54%; restructuring in PC and mix/pricing in PM are driving sustained margin expansion .
  • Guidance prudence: FY25 ranges widened (sales $1.25–$1.40B; EBITDA $380–$415M) given lower auto production forecasts; monitor tariff-policy developments and NA auto build trajectory .
  • PM sensitivity: management quantifies −$15–$20M 2025 PM EBITDA sensitivity to a 9–10% NA auto decline; filtration provides a lower-margin buffer if needed .
  • PC turnaround progressing: sales reset by design; EBITDA near breakeven with clear drivers (lower CTO costs, cost actions, mix) and strategic options for Industrial Specialties under review .
  • APT execution: margin lift to 29.6% ahead of Q2 boiler outage; competition in China persists—watch price discipline and mix .
  • Balance sheet improving: net leverage at 3.3x; path to <2.8x by year-end supported by FCF discipline and working capital management .
  • Trade idea: upside skew if auto production stabilizes and PC margin trajectory continues; downside risks centered on deeper auto declines and APT pricing in China .